Brian Lenz
2018 - ADMA Biologics
In 2018, Brian Lenz earned a total compensation of $940.1K as Executive Vice President and Chief Financial Officer at ADMA Biologics, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $107,105 |
|---|---|
| Option Awards | $312,230 |
| Salary | $366,800 |
| Other | $153,959 |
| Total | $940,094 |
Lenz received $366.8K in salary, accounting for 39% of the total pay in 2018.
Lenz also received $107.1K in bonus, $312.2K in option awards and $154K in other compensation.
Rankings
In 2018, Brian Lenz's compensation ranked 9,494th out of 14,244 executives tracked by ExecPay. In other words, Lenz earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,494 out of 14,244 | 33rd |
Division Manufacturing | 3,811 out of 5,758 | 34th |
Major group Chemicals And Allied Products | 1,435 out of 2,119 | 32nd |
Industry group Drugs | 1,209 out of 1,808 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 238 out of 339 | 30th |
Source: SEC filing on April 24, 2019.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2018.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019